Literature DB >> 8304780

Epithelioid cell melanomas have greater DNA ploidy abnormalities than spindle cell melanomas: cytological evidence for a higher malignant potential of the former.

H I Chi1, Y Uyeda, Y Umebayashi, F Otsuka.   

Abstract

The cellular DNA ploidy of 30 cases of malignant melanoma was measured by 4',6-diamidino-2-phenylindole-DNA (DAPI-DNA) microfluorometry. DNA histograms and DNA index values were compared among melanomas of different cell morphology. Epithelioid cell melanomas often showed greater DNA aneuploidy than spindle cell melanomas in terms of histographic pattern. DNA index values of the former (mean +/- standard error, 1.84 +/- 0.31) were significantly higher than those of the latter (1.55 +/- 0.24; P < 0.05). The DNA index values of mixed-type melanomas were intermediate. These results indicate that the epithelioid cell melanomas have greater DNA ploidy abnormalities which are usually correlated with a greater malignant potential in pigmentary neoplasms. Thus our results confirm clinical evidence that melanoma patients with the epithelioid type of cells have a poorer prognosis than those with the spindle type of cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8304780     DOI: 10.1007/BF00372134

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  19 in total

Review 1.  DNA in human tumors: a cytophotometric study.

Authors:  N Böhm; W Sandritter
Journal:  Curr Top Pathol       Date:  1975

2.  Porokeratosis as a premalignant condition of the skin. Cytologic demonstration of abnormal DNA ploidy in cells of the epidermis.

Authors:  F Otsuka; A Shima; Y Ishibashi
Journal:  Cancer       Date:  1989-03-01       Impact factor: 6.860

3.  Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.

Authors:  A Breslow
Journal:  Ann Surg       Date:  1970-11       Impact factor: 12.969

4.  Disseminated porokeratosis accompanying multicentric Bowen's disease. Characterization of porokeratotic lesions progressing to Bowen's disease.

Authors:  F Otsuka; J Huang; K Sawara; A Asahina; Y Ishibashi
Journal:  J Am Acad Dermatol       Date:  1990-08       Impact factor: 11.527

5.  [Topographical differences in cellular DNA content between the radial growth phase and the vertical growth phase of superficial spreading melanoma].

Authors:  H I Chi; F Otsuka; Y Ishibashi
Journal:  Nihon Hifuka Gakkai Zasshi       Date:  1989-04

6.  Use of DAPI cytofluorometric analysis of cellular DNA content to differentiate Spitz nevus from malignant melanoma.

Authors:  H I Chi; Y Ishibashi; A Shima; I Mihara; F Otsuka
Journal:  J Invest Dermatol       Date:  1990-08       Impact factor: 8.551

7.  Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations.

Authors:  S B Ewers; E Långström; B Baldetorp; D Killander
Journal:  Cytometry       Date:  1984-07

8.  Immunohistochemical study of malignant melanoma.

Authors:  T Hirano
Journal:  Acta Pathol Jpn       Date:  1986-05

9.  Cytophotometric DNA analysis of mucosal and submucosal carcinoma of the esophagus.

Authors:  K Sugimachi; H Ide; T Okamura; H Matsuura; M Endo; K Inokuchi
Journal:  Cancer       Date:  1984-06-15       Impact factor: 6.860

10.  Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study.

Authors:  J H von Roenn; S M Kheir; J M Wolter; J S Coon
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

View more
  2 in total

1.  Prognostic significance in malignant melanoma of nuclear DNA content measured by a microfluorimetric method.

Authors:  Y Umebayashi; F Otsuka
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

2.  BRAFV600E immunopositive melanomas show low frequency of heterogeneity and association with epithelioid tumor cells: a STROBE-compliant article.

Authors:  Ivana Verlinden; Karin van den Hurk; Ruud Clarijs; Arjan P Willig; Cecile M H A Stallinga; Guido M J M Roemen; Joost J van den Oord; Axel zur Hausen; Ernst-Jan M Speel; Véronique J L Winnepenninckx
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.